Do Traders Think ENDRA Life Sciences Inc (NDRA) Can Turn Around Friday?

Overall market sentiment has been high on ENDRA Life Sciences Inc (NDRA) stock lately. NDRA receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

ENDRA Life Sciences Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on NDRA!

See Full NDRA Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With NDRA Stock Today?

ENDRA Life Sciences Inc (NDRA) stock is trading at $1.05 as of 10:23 AM on Friday, Sep 15, a loss of -$0.18, or -14.54% from the previous closing price of $1.23. The stock has traded between $1.03 and $1.20 so far today. Volume today is high. So far 328,752 shares have traded compared to average volume of 177,155 shares. To screen for more stocks like ENDRA Life Sciences Inc click here.

More About ENDRA Life Sciences Inc

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures. Click Here to get the full Stock Report for ENDRA Life Sciences Inc stock.